sodium fluoride has been researched along with Smoldering Multiple Myeloma in 1 studies
Smoldering Multiple Myeloma: An asymptomatic and slow-growing PLASMA CELL dyscrasia characterized by presence of MYELOMA PROTEINS and clonal bone marrow plasma cells without end-organ damage (e.g., renal impairment). It is distinguished from MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE by a much higher risk of progression to symptomatic MULTIPLE MYELOMA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arani, LS | 1 |
| Zirakchian Zadeh, M | 1 |
| Saboury, B | 1 |
| Revheim, ME | 1 |
| Øestergaard, B | 1 |
| Borja, AJ | 1 |
| Samadi Samarin, D | 1 |
| Mehdizadeh Seraj, S | 1 |
| Kalbush, E | 1 |
| Ayubcha, C | 1 |
| Morris, MA | 1 |
| Werner, TJ | 1 |
| Abildgaard, N | 1 |
| Høilund-Carlsen, PF | 1 |
| Alavi, A | 1 |
1 other study available for sodium fluoride and Smoldering Multiple Myeloma
| Article | Year |
|---|---|
Assessment of atherosclerosis in multiple myeloma and smoldering myeloma patients using
Topics: Atherosclerosis; Fluorine Radioisotopes; Humans; Multiple Myeloma; Positron Emission Tomography Comp | 2021 |